Latest Commercial Scale Up News

Mesoblast has raised A$260 million through a global private placement to fund the US commercial launch of its FDA-approved cell therapy Ryoncil® and accelerate clinical development in chronic low back pain.

Livium and Mineral Resources have agreed to extend their joint development agreement, funding additional optimisation activities for the LieNA® lithium extraction technology and setting the stage for a 50/50 joint venture.

Galan Lithium has secured the full Phase 2 mining permit for its Hombre Muerto West project, enabling a production scale-up to 21,000 tonnes per annum of lithium carbonate equivalent. Positioned in the lowest cost quartile, this milestone cements Galan’s role as a key player in the global lithium market.